Travere Therapeutics Inc. (TVTX)
NASDAQ · Healthcare
Travere Therapeutics Inc. Revenue 2011–2025
Travere Therapeutics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Travere Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 127.2 M, a 55.63% increase year-over-year.
- Travere Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 488.2 M, a 149.76% increase year-over-year.
- Travere Therapeutics Inc. annual revenue for 2025 was 490.7 M, a 110.45% increase from 2024.
- Travere Therapeutics Inc. annual revenue for 2024 was 233.2 M, a 60.55% increase from 2023.
- Travere Therapeutics Inc. annual revenue for 2023 was 145.2 M, a 32.69% increase from 2022.
- Travere Therapeutics Inc. annual revenue for 2022 was 109.5 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Travere Therapeutics Inc. Market Cap — FAQ
Travere Therapeutics Inc. (TVTX) market cap over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TVTX's market cap history?
The chart and table above show Travere Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.